Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,945 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulatory T Cells in GVHD Therapy.
Guo WW, Su XH, Wang MY, Han MZ, Feng XM, Jiang EL. Guo WW, et al. Among authors: wang my. Front Immunol. 2021 Jun 18;12:697854. doi: 10.3389/fimmu.2021.697854. eCollection 2021. Front Immunol. 2021. PMID: 34220860 Free PMC article. Review.
Impact of HLA-B leader matching on clinical outcomes after haploidentical transplantation using antithymocyte globulin-based conditioning.
Wang M, Guo W, Zheng X, Wang J, Liu J, Cao Y, Zhang R, Chen X, Zhai W, Ma Q, Wei J, Huang Y, Yang D, He Y, Pang A, Feng S, Han M, Jiang E. Wang M, et al. Bone Marrow Transplant. 2023 Jan;58(1):94-96. doi: 10.1038/s41409-022-01842-z. Epub 2022 Oct 11. Bone Marrow Transplant. 2023. PMID: 36220922 No abstract available.
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases.
Cao Y, Gong X, Feng Y, Wang M, Hu Y, Liu H, Liu X, Qi S, Ji Y, Liu F, Zhu H, Guo W, Shen Q, Zhang R, Zhao N, Zhai W, Song X, Chen X, Geng L, Chen X, Zheng X, Ma Q, Tang B, Wei J, Huang Y, Ren Y, Song K, Yang D, Pang A, Yao W, He Y, Shang Y, Wan X, Zhang W, Zhang S, Sun G, Feng S, Zhu X, Han M, Song Z, Guo Y, Sun Z, Jiang E, Chen J. Cao Y, et al. Am J Hematol. 2023 Feb;98(2):309-321. doi: 10.1002/ajh.26792. Epub 2023 Jan 2. Am J Hematol. 2023. PMID: 36591789 Free PMC article.
JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid-derived suppressor cells via the JAK/STAT and ROS-MAPK/NF-κB signalling pathways in acute graft-versus-host disease.
Cao Y, Wang J, Jiang S, Lyu M, Zhao F, Liu J, Wang M, Pei X, Zhai W, Feng X, Feng S, Han M, Xu Y, Jiang E. Cao Y, et al. Clin Transl Immunology. 2023 Feb 25;12(2):e1441. doi: 10.1002/cti2.1441. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36855558 Free PMC article.
1,945 results